Henry joined Gilde Healthcare in 2018 and serves as Investment Manager with a focus on the healthtech sector.

He previously worked in business development for Biolinq, a US-based start-up, developing a novel generation of continuous glucose monitoring. Prior to this, Henry worked at Merck KGaA and gained experience in deal sourcing and evaluation at M Ventures, in the Netherlands. He initially began his career as a management consultant in London for several years.

Henry holds a Master’s degree in Bioscience Enterprise from the University of Cambridge.